BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3226186)

  • 1. [What should be done in resistant or relapsing Hodgkin's disease?].
    Bladé J; Montserrat E
    Med Clin (Barc); 1988 Oct; 91(11):413-5. PubMed ID: 3226186
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of recurrent Hodgkin's lymphoma. I. Radiotherapy and conventional chemotherapy].
    Pfreundschuh M; Diehl V
    Dtsch Med Wochenschr; 1989 Jun; 114(22):880-4. PubMed ID: 2656184
    [No Abstract]   [Full Text] [Related]  

  • 3. New therapies in Hodgkin's lymphoma.
    Bartlett N
    Clin Adv Hematol Oncol; 2004 Feb; 2(2):80, 83. PubMed ID: 16163165
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
    Dawson LA; Saito NG; Ratanatharathorn V; Uberti JP; Adams PT; Ayash LJ; Reynolds CM; Silver SM; Schipper MJ; Lichter AS; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):208-18. PubMed ID: 15093918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hodgkin's disease - new treatment strategies toward the cure of patients.
    Jox A; Sieber M; Wolf J; Diehl V
    Cancer Treat Rev; 1999 Jun; 25(3):169-76. PubMed ID: 10425259
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hodgkin's disease: treatment of clinical stages II3+A, IB, IIB, IIIA and IIIB with short chemotherapy (3 MOPP, or 3 CVPP), splenectomy and limited irradiation. Results after 4 years of a prospective protocol including 94 patients].
    Andrieu JM; Casassus P; Coscas Y; Darmont J; Goubeau C; Katz M; Jacquillat C; Tricot G; Weil M
    Bull Cancer; 1982; 69(4):321-9. PubMed ID: 6897520
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative evaluation of the efficacy of chemotherapy and chemoradiotherapy of stage IIIB Hodgkin's disease].
    Kanaev SV; Gershanovich ML; Malinin AP; Kholin AV
    Vopr Onkol; 1988; 34(4):438-45. PubMed ID: 3376456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of erythrocyte mean corpuscular volume during cytotoxic therapy as a predictive parameter of the risk of secondary leukemia in Hodgkin's disease.
    de Gramont A; Rioux E; Drolet Y; Delage JM
    Cancer Treat Rep; 1984 Dec; 68(12):1467-70. PubMed ID: 6509452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combined chemotherapy in disseminated Hodgkin's disease].
    Armata J
    Pol Tyg Lek; 1972 Jul; 27(24):927-9. PubMed ID: 4557231
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of Hodgkin's disease including the staging laparotomy].
    Yosida T; Nakanisi J; Kobayasi S; Ohtake S; Ito K; Nakamura S; Hattori K; Saito Y; Tanimoto K
    Rinsho Ketsueki; 1984 Jun; 25(6):827-34. PubMed ID: 6548266
    [No Abstract]   [Full Text] [Related]  

  • 11. [Drug therapy of Hodgkin's disease].
    Gallmeier WM; Bruntsch U
    Internist (Berl); 1981 May; 22(5):289-300. PubMed ID: 7019138
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hodgkin's disease].
    van den Berg H
    Ned Tijdschr Geneeskd; 1997 Sep; 141(39):1877-8. PubMed ID: 9545750
    [No Abstract]   [Full Text] [Related]  

  • 13. [High-dose chemotherapy and autologous stem cell transplantation for refractory and relapsing Hodgkin's disease as first-line therapy-- studies at Sheba Medical Center--Tel Hashomer].
    Avigdor A; Hardan I; Shpilberg O; Raanani P; Grotto I; Ben-Bassat I
    Harefuah; 2000 Sep; 139(5-6):174-9, 248, 247. PubMed ID: 11062945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hodgkin's disease and hypothermia: case report and review of the literature.
    Robin V; Lebacq J; Michaux L; Ferrant A
    Ann Hematol; 2002 Feb; 81(2):106-7. PubMed ID: 11907792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of early stages of Hodgkin's disease with novantrone, vincristine, vinblastine, prednisone, and radiotherapy.
    Hagemeister FB; Purugganan R; Fuller L; McLaughlin P; Swan F; Romaguera J; Rodriguez M; Cabanillas F
    Semin Hematol; 1994 Apr; 31(2 Suppl 3):36-43. PubMed ID: 8073308
    [No Abstract]   [Full Text] [Related]  

  • 16. [Trial of combined radiotherapy and chemotherapy in the treatment of Hodgkin's disease].
    Tubiana M; Laugier A; Hayat M; Attie E; Mathé G
    Nouv Rev Fr Hematol; 1966; 6(1):134-42. PubMed ID: 4222293
    [No Abstract]   [Full Text] [Related]  

  • 17. [Questions and aspects of radiotherapy of adult patients with localized supradiaphragmatic stage (CS I/II) Hodgkin's disease. 1. Questions and aspects on indications for primary and adjuvant radiotherapy].
    Glanzmann C; Lütolf UM
    Strahlenther Onkol; 1993 Aug; 169(8):449-58. PubMed ID: 8356505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy strategies to improve the control of Hodgkin's disease: the Richard and Hinda Rosenthal Foundation Award Lecture.
    Bonadonna G
    Cancer Res; 1982 Nov; 42(11):4309-20. PubMed ID: 6181867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MOPP, ABVD, or both to treat Hodgkin's disease.
    Martino R; Nomdedeu J; Brunet S
    N Engl J Med; 1993 Apr; 328(14):1045; author reply 1045-6. PubMed ID: 7680766
    [No Abstract]   [Full Text] [Related]  

  • 20. [Evaluation of the effectiveness of chemoradiotherapy of stage IIIA Hodgkin's disease].
    Kanaev SV; Gershanovich ML; Malinin AP; Kholin AV
    Med Radiol (Mosk); 1987 May; 32(5):16-21. PubMed ID: 3586917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.